Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,378,000 | 9,991,000 | 6,807,000 | 13,271,000 | 14,000,000 |
| Marketable Securities | 339,000 | 344,000 | 305,000 | 2,693,000 | 710,000 |
| Receivables | 8,070,000 | 8,252,000 | 7,845,000 | 8,975,000 | 8,766,000 |
| Inventories | 6,123,000 | 6,094,000 | 5,728,000 | 6,956,000 | 6,952,000 |
| Other current assets | 3,765,000 | 3,639,000 | 31,763,000 | 3,668,000 | 3,685,000 |
| TOTAL | $26,675,000 | $28,320,000 | $52,448,000 | $35,563,000 | $34,113,000 |
| Non-Current Assets | |||||
| PPE Net | 11,878,000 | 12,290,000 | 12,415,000 | 15,696,000 | 15,745,000 |
| Investments And Advances | 8,284,000 | 8,204,000 | 10,122,000 | 10,697,000 | 10,807,000 |
| Intangibles | 56,000,000 | 53,754,000 | 53,316,000 | 74,013,000 | 72,989,000 |
| Other Non-Current Assets | 13,134,000 | 13,726,000 | 9,645,000 | 9,594,000 | 9,340,000 |
| TOTAL | $89,296,000 | $87,974,000 | $85,498,000 | $110,000,000 | $108,881,000 |
| Total Assets | $115,971,000 | $116,294,000 | $137,946,000 | $145,563,000 | $142,994,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,017,000 | 7,857,000 | 7,428,000 | 9,678,000 | 9,177,000 |
| Accounts payable and accrued liabilities | 4,669,000 | 4,752,000 | 4,638,000 | 5,556,000 | 4,970,000 |
| Other current liabilities | 12,943,000 | 15,012,000 | 10,520,000 | 12,335,000 | 12,409,000 |
| TOTAL | $28,220,000 | $30,111,000 | $56,127,000 | $29,607,000 | $28,327,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,131,000 | 20,364,000 | 21,225,000 | 22,470,000 | 22,605,000 |
| Other Non-Current Liabilities | 9,341,000 | 8,594,000 | 7,864,000 | 7,320,000 | 6,390,000 |
| TOTAL | $35,153,000 | $34,679,000 | $34,512,000 | $37,264,000 | $36,648,000 |
| Total Liabilities | $63,373,000 | $64,790,000 | $90,639,000 | $66,871,000 | $64,975,000 |
| Shareholders' Equity | |||||
| Common Shares | 936,000 | 936,000 | 944,000 | 944,000 | 944,000 |
| Retained earnings | 51,668,000 | 50,557,000 | 46,348,000 | 77,739,000 | 77,063,000 |
| Other shareholders' equity | 74,000 | 78,000 | 78,000 | 78,000 | 81,000 |
| TOTAL | $52,598,000 | $51,504,000 | $47,307,000 | $78,692,000 | $78,019,000 |
| Total Liabilities And Equity | $115,971,000 | $116,294,000 | $137,946,000 | $145,563,000 | $142,994,000 |